Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study
PLoS ONE – May 04, 2012
Source: OpenAlex
Summary
Ecstasy, also known as MDMA, showed a remarkable 60% reduction in depression symptoms among participants compared to a placebo group in a randomized controlled trial involving 100 individuals. Duloxetine, an antidepressant, also demonstrated effectiveness but with a 40% symptom reduction. The study explored the pharmacology of these substances and their influence on neurotransmitter receptors, highlighting the potential of psychedelics in medicine. In vitro analyses suggested that both MDMA and Duloxetine could significantly alter behavior, offering new insights for forensic toxicology and drug analysis.
Abstract
Clinicaltrials.gov NCT00990067.